Product Information
SECUADO 3.8 MG/24 HR PATCH is a brand product labeled by Noven Therapeutics, LLC, priced at $49.0677 per EA under NDC 68968017203. Its NADAC has been published 116 times since Jul 17, 2024.
FDA first approved this application on Oct 11, 2019.
Strength
3.8 mg/d
Manufacturer
Noven Therapeutics, LLCNDC
68968017203
Classification
Brand
Dosage Form
FILM, EXTENDED RELEASE
Route
TRANSDERMAL
Effective Date
9/23/2026
Active Ingredients
ASENAPINEApproval Type
New Drug (NDA)
FDA Application
NDA212268FDA Approved
10/11/2019
On Market Since
2/12/2020
Pharmacological Classes
Price Statistics
The NADAC for SECUADO 3.8 MG/24 HR PATCH has been published 116 times since Jul 17, 2024, and over the history we have for it it has risen 10.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $49.0677 per EA |
|---|---|
| All-time high | $49.1206 (Sep 16, 2026) |
| All-time low | $44.4356 (Aug 21, 2024) |
| 52-week high | $49.1206 |
| 52-week low | $46.6496 |
| Median price | $46.7047 |
| Average price | $47.0396 |
| Largest weekly change | +5.0% (Dec 31, 2025) |
| Weeks tracked | 116 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ASENAPINE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Noven Therapeutics, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ASENAPINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SECUADO 3.8 MG/24 HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for SECUADO 3.8 MG/24 HR PATCH, manufactured by Noven Therapeutics, LLC, is $49.0677 per EA (NDC 68968017203), effective Sep 30, 2026.
How has the price of SECUADO 3.8 MG/24 HR PATCH changed over time?
Over the history we have for it, the NADAC for SECUADO 3.8 MG/24 HR PATCH has risen 10.3%. It has been tracked across 116 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for SECUADO 3.8 MG/24 HR PATCH?
Since Jul 17, 2024, the NADAC for SECUADO 3.8 MG/24 HR PATCH has ranged from a low of $44.4356 (Aug 21, 2024) to a high of $49.1206 (Sep 16, 2026), with a median of $46.7047 per EA.
Are there cheaper alternatives to SECUADO 3.8 MG/24 HR PATCH?
No other NADAC-published product currently shares the active ingredient and strength of SECUADO 3.8 MG/24 HR PATCH in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SECUADO 3.8 MG/24 HR PATCH?
SECUADO 3.8 MG/24 HR PATCH (NDC 68968017203) is labeled by Noven Therapeutics, LLC, and CMS classifies it as a brand product.